Top States: CA | DC | FL | GA | MA | NC | NJ | NY | OH | TX | WA |

E’shee Clinical Esthetic Launches High-Tech Skin Serum

By :: Tue, 21 Feb 2012 06:58:22 -0400 EDT

E'shee Clinical EstheticPHILADELPHIA, Pa., Feb. 21, 2012 (SEND2PRESS NEWSWIRE) — E’shee Clinical Esthetic announced this week a new addition to its product line of skin serums – Elixir of Life KI Therapy Serum – designed to deliver ultimate skin rejuvenation.

This new skin care product is based on a combination of stem cell and infrared nanotechnology. It is the most potent skin care formula that combines gene therapy (FGF-1 peptide) and Far Infrared Powder (FIR) to rejuvenate and restore the beauty of damaged or aging skin.

This new Elixir of Life Serum helps to activate the body’s stem cells to repair damaged tissue and skin regeneration.

“Results are proven. The FGF-1 peptide – the stem cell activator – helps to increase new skin cell growth at least 10-20 times faster than with other skin care products,” says Nataly Giter, founder, E’shee Clinical Esthetic.

Elixir of Life is ideal for people with circulation problems due to external factors such as pollution, and physical problems due to illness, medications or smoking. It works to repair dark circles and broken capillaries; delays the overall skin aging process through skin repair and re-growth; and also works to properly heal and repair scar tissue.

People of all ages – men and women – will see physical results within 30 days. Skin will be healthier and firmer with a smoother and more even skin tone.

“Ultimately, this new product helps to restore blood flow; aids with toxin removal; repairs broken capillaries; and reverses skin damage. We are very excited to offer this to anyone wishing to dramatically improve their skin care,” says Giter.

About E’shee Clinical Esthetic:
E’shee was launched in 2009 by Nataly Giter, a hands-on skin care professional with more than 20 years of experience. Through research and practical experience, she learned about the most effective ingredients for advanced skin care and became associated with Dr. Chiu, a professor from Ohio University and the first global pioneer to clone the human FGF-1 gene.

Together with Dr. Chiu and their combined connections to industry professionals, they utilized FGF-1 to create an extraordinary anti-aging product line, using 99 percent pure FGF-1 peptide – the best quality available outside of the human body.

For more information on E’shee Clinical Esthetic, visit: www.esheeesthetic.com or www.esheeesthetic.com/wordpress/ .

* Photo 300dpi download for media: Send2Press.com/mediaboom/12-0221-eshee_300dpi.jpg .
* Photo Caption: Elixir of Life Serum.

News Source: E’shee Clinical Esthetic :: This press release was issued on behalf of the news source by Send2Press® Newswire, a service of Neotrope®. View all current news at: http://Send2PressNewswire.com .

More Information:

E’shee was launched in 2009 by Nataly Giter, a hands-on skin care professional with more than 20 years of experience. Through research and practical experience, she learned about the most effective ingredients for advanced skin care and became associated with Dr. Chiu, a professor from Ohio University and the first global pioneer to clone the human FGF-1 gene.

Press Release Copr. © E'shee Clinical Esthetic (or “news source”) and Send2Press® Newswire. Permission granted for reproduction by news portals, aggregators and news indexes provided original attribution to this site and news source is retained. Cannot be used for commercial purposes/advertising or keyword marketing. All other rights reserved.

This press release has had 1,383 views so far.
http://www.send2press.com/newswire/2012-02-0221-003.shtml
 
DISCLAIMER: the above press release content is believed accurate but not guaranteed, and is based on business news supplied by the "news source." The noted source is solely responsible for its accuracy. Financial/Stock news may contain forward looking statements. Neotrope/Send2Press (this Web site) makes no claims of accuracy or suitability for any purpose. Any opinions expressed by representatives of company(s) mentioned in news and profiles are solely those of the person indicated, and do not reflect any opinion or policy of Neotrope® or the Send2Press® Newswire service. Your use of any information contained herein is done solely at your own risk, and you are fully responsible for using any information herein, or on sites mentioned or linked to in the article. All trademarks acknowledged.